RhD variants in Caucasians: consequences for checking clinically relevant alleles

被引:53
作者
Ansart-Pirenne, H
Asso-Bonnet, M
Le Pennec, PY
Roussel, M
Patereau, C
Noizat-Pirenne, F
机构
[1] Hop Henri Mondor, Etablissement Francais Sang Ile France, F-94000 Creteil, France
[2] Hop Henri Mondor, Natl Blood Grp Ref Ctr, F-94000 Creteil, France
关键词
D O I
10.1111/j.1537-2995.2004.04063.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Weak D type carriers cannot be immunized against D except when antigen density is below 400 antigens per RBC, whereas partial D carriers can produce anti-D. STUDY DESIGN AND METHODS: A total of 168 blood samples from Caucasian individuals were studied because of weak D expression and/or anti-D production. Serologic analysis and molecular analysis were performed. RESULTS: In total, 70 partial D and 62 weak D were identified. Among weak D samples, 30 weak D Type 1 and 21 weak D Type 2 alleles were found. Five new alleles were characterized carrying 399G > T 680T > C, 833G > A, 851 C > T, and 1015G > A, respectively. According to previous studies, antigen density was up to 500 for weak D Type 1 and 2, except when there was a dCe haplotype in trans. Antigen density was below 400 antigens per red blood cell for the new variants and most other weak D variants. CONCLUSION: These results provide molecular characterization of five new D variants. They also suggest that it would be advantageous to develop in routine laboratories weak D Type 1 and 2 genotyping for serologically depressed D antigen. It will help to avoid wasting of D-red blood cell units because carriers may safely receive D+ units.
引用
收藏
页码:1282 / +
页数:6
相关论文
共 13 条
[1]   DEFINING THE RH BLOOD-GROUP ANTIGENS - BIOCHEMISTRY AND MOLECULAR-GENETICS [J].
CARTRON, JP .
BLOOD REVIEWS, 1994, 8 (04) :199-212
[2]  
DOSCHER D, 2003, TRANSF MED HEMOTH S1, V30, P3
[3]   Section 1B:: Rh flow cytometry -: Coordinator's report.: Rhesus index and antigen density:: an analysis of the reproducibility of flow cytometric determination [J].
Flegel, WA ;
Curin-Serbec, V ;
Delamaire, M ;
Donvito, B ;
Ikeda, H ;
Jorgensen, J ;
Kumpel, B ;
Le Pennec, PY ;
Písacka, M ;
Tani, Y ;
Uchikawa, M ;
Wendel, S ;
Wagner, FF .
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2002, 9 (01) :33-42
[4]  
Flegel Willy A, 2002, Clin Lab, V48, P53
[5]  
Huang CH, 1999, AM J HEMATOL, V62, P25, DOI 10.1002/(SICI)1096-8652(199909)62:1<25::AID-AJH5>3.0.CO
[6]  
2-K
[7]   RHD sequencing:: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis [J].
Legler, TJ ;
Maas, JH ;
Köhler, M ;
Wagner, T ;
Daniels, GL ;
Perco, P ;
Panzer, S .
TRANSFUSION MEDICINE, 2001, 11 (05) :383-388
[8]   Rare RHCE phenotypes in black individuals of Afro-Caribbean origin:: identification and transfusion safety [J].
Noizat-Pirenne, F ;
Lee, K ;
Le Pennec, PY ;
Simon, P ;
Kazup, P ;
Bachir, D ;
Rouzaud, AM ;
Roussel, M ;
Juszczak, G ;
Ménanteau, C ;
Rouger, P ;
Kotb, R ;
Cartron, JP ;
Ansart-Pirenne, H .
BLOOD, 2002, 100 (12) :4223-4231
[9]   DAL: a new partial RHD phenotype [J].
Noizat-Pirenne, F ;
Le Pennec, PY ;
Mouro, I ;
Roussel, M ;
Cartron, JP ;
Ansart-Pirenne, H .
TRANSFUSION, 2001, 41 (07) :971-972
[10]  
Wagner FF, 2000, BLOOD, V95, P2699